Atopalm Hemorrhoidal Pain Relieving
NDC Package 51141-0220-1
Package Information
Atopalm Hemorrhoidal Pain Relieving is do not use if foil seal under cap is broken or missing.Adults ■ when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Marketed by Neopharm Usa, this product is identified by NDC 51141-0220 and is authorized under FDA application part346.
Identification & Billing
- RxCUI: 1293649 - glycerin 14.4 % / phenylephrine HCl 0.25 % / pramoxine HCl 1 % / white petrolatum 15 % Rectal Cream
- RxCUI: 1293649 - glycerin 144 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream
- RxCUI: 1293649 - glycerin 14.4 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 15 % Rectal Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51141 - Neopharm Usa
- 51141-0220 - Atopalm Hemorrhoidal Pain Relieving
- 51141-0220-1 - 1 TUBE in 1 CARTON / 28.3 g in 1 TUBE
- 51141-0220 - Atopalm Hemorrhoidal Pain Relieving
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51141-0220-1 identifies a specific commercial package of 1 tube in 1 carton / 28.3 g in 1 tube of Atopalm Hemorrhoidal Pain Relieving, labeled by Neopharm Usa. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Usa on January 17, 2012. The current certification is valid through December 31, 2017.
How is this Neopharm Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141022001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.